Dcgi Rsquo

Rediff.com » News » Dcgi Rsquo

News for Dcgi Rsquo

News
Business

India will wait for DCGI nod to restart Oxford vaccine trial

The global trials were halted after a study participant suffered a ‘potentially unexplained illness', reports Sohini Das. IMAGE: Serum Institute of India is the Indian partner of AstraZeneca......

India probes four cough syrups after 66 Gambian children's deaths

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially......

SIIto test Novavax's Omicron-specific vaccine

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for ‘examination, test, and analysis’,......

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

If things go according to plan, the vaccine would be available in the market by the end of this year. IMAGE: Kindly note that this image has been posted for representational purposes only.......

Novovax Covid vaccine likely to get nod in India ahead of US

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......

Pharma cos okay with QR codes to combat counterfeit drugs

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say......

What is Schedule M and why it's mandatory for all pharma units

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will......

Regulatory woes torpedo PE/VC deals in e-pharma sector

With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture......

Gaps in clinical trial data delay compensation

Despite clinical trials coming under scrutiny, nothing much has changed on ground as many irregularities continue to exist.While the office of the Drugs Controller General of India is still......

Drug regulator to make routine inspection of Chinese suppliers

The Indian drug regulator is set to conduct routine inspections at the manufacturing facilities of Chinese and other foreign companies supplying active pharmaceutical ingredients to domestic......

Rediff News

Dcgi Rsquo

News for Dcgi Rsquo

India will wait for DCGI nod to restart Oxford vaccine trial

India probes four cough syrups after 66 Gambian children's deaths

SIIto test Novavax's Omicron-specific vaccine

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Novovax Covid vaccine likely to get nod in India ahead of US

Pharma cos okay with QR codes to combat counterfeit drugs

What is Schedule M and why it's mandatory for all pharma units

Regulatory woes torpedo PE/VC deals in e-pharma sector

Gaps in clinical trial data delay compensation

Drug regulator to make routine inspection of Chinese suppliers

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS